Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-03-20
2007-03-20
Siew, Jeffrey (Department: 1642)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S300000, C530S324000, C530S325000, C530S326000
Reexamination Certificate
active
10198069
ABSTRACT:
The present invention is directed to methods of treating conditions requiring removal or destruction of harmful or unwanted cells in a patient, such as benign and malignant tumors, using compounds containing or based on peptides comprising a part of the amino acid sequence of a neural thread protein.
REFERENCES:
patent: 5830670 (1998-11-01), de la Monte et al.
patent: 5948634 (1999-09-01), de la Monte et al.
patent: 5948888 (1999-09-01), De La Monte et al.
patent: 6071705 (2000-06-01), Wands et al.
patent: WO 98 38204 (1998-09-01), None
patent: WO 00 34477 (2000-06-01), None
patent: WO 00 55198 (2000-09-01), None
patent: WO 00 56767 (2000-09-01), None
patent: WO 00 58339 (2000-10-01), None
patent: WO 00 58495 (2000-10-01), None
patent: WO 00 63230 (2000-10-01), None
patent: WO 01 46237 (2001-06-01), None
patent: WO 02 097030 (2002-12-01), None
Bork (2000) “Powers and Pitfalls in Sequence Analysis: The 70% Hurdle.” Genome Research 10:398-400.
Skolnick and Fetrow (2000) “From gene to protein structure and function: novel applications of computational approaches in the genomic era.” Trends inBiotech. 18(1): 34-39.
Doerks et al., (Jun. 1998) “Protein annotation: detective work for function prediction.” Trends in Genetics 14(6): 248-250.
Smith and Zhang (Nov. 1997) “The challenges of genome sequence annotation or ‘The devil is in the details’.” Nature Biotechnology 15:1222-1223.
Brenner (Apr. 1999) “Errors in genome annotation.” Trends in Genetics 15(4): 132-133.
Bork and Bairoch (Oct. 1996) “Go hunting in sequence databases but watch out for the traps.” Trends in Genetics 12(10): 425-427.
Burgess et al. (J. Cell Biol. 111:2129-2138, 1990).
Lazar et al. ( Mol. Cell Biol. 8:1247-1252, 1998).
Wen et al. (Proc. Natl. Acad. Sci. U.S.A. 98: 4622-4627, 2001).
Golubnitschaja-Labudova et al.: “Altered gene expression in lymphocytes of patients with normal-tension glaucoma” Current Eye Research, vol. 21, No. 5, 2000, pp. 867-876.
Database WPI: Derwent Publications Ltd., London, GB; AN 2001-530465 XP002241203 & CN 1 300 783 (Shengyuan Gene Dev Co Ltd Shanghai), Jun. 27, 2001, abstract.
De La Monte et al.: “Characterization of the AD7C-NTP cDNA Expression in Alzheimer's Disease and Measurement of a 41-kD Protein in Cerebrospinal Fluid” Journal of Clinical Investigation, vol. 100, No. 12, Dec. 1997, pp. 3093-3104.
PCT International Search Report for PCT/CA02/01105, date of mailing Sep. 30, 2003.
Fetterolf Brandon
Hunton & Williams LLP
Nymox Corporation
Siew Jeffrey
LandOfFree
Peptides effective in the treatment of tumors and other... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptides effective in the treatment of tumors and other..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides effective in the treatment of tumors and other... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3804718